Works matching Pierce, M. B. (Maris Bryant), 1811-1874

Results: 1404
    1
    2
    3
    4
    5
    6
    7
    8

    Erratum: Malcolm A. Smith, John M. Maris, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, Christopher L. Morton, Jianrong Wu, Peter G. Smith, Jie Yu and Peter J. Houghton. Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2012 August; 59(2):246-253

    Published in:
    Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 772, doi. 10.1002/pbc.24291
    By:
    • Smith, Malcolm A.;
    • Maris, John M.;
    • Gorlick, Richard;
    • Kolb, E. Anders;
    • Lock, Richard;
    • Carol, Hernan;
    • Keir, Stephen T.;
    • Reynolds, C. Patrick;
    • Kang, Min H.;
    • Morton, Christopher L.;
    • Wu, Jianrong;
    • Smith, Peter G.;
    • Yu, Jie;
    • Houghton, Peter J.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    β-gliadin proteins from Maris Widgeon wheat.

    Published in:
    Journal of the Science of Food & Agriculture, 1985, v. 36, n. 9, p. 833, doi. 10.1002/jsfa.2740360912
    By:
    • Khan, Ahmed S.;
    • Waldron, Norman M.;
    • Thiang, Lek C.
    Publication type:
    Article
    24

    Gliadin proteins from maris widgeon wheat.

    Published in:
    Journal of the Science of Food & Agriculture, 1976, v. 27, n. 9, p. 838, doi. 10.1002/jsfa.2740270908
    By:
    • Patey, Alan L.;
    • Waldron, Norman M.
    Publication type:
    Article
    25
    26
    27
    28
    29

    Additions to the genus Gimesia: description of Gimesia alba sp. nov., Gimesia algae sp. nov., Gimesia aquarii sp. nov., Gimesia aquatilis sp. nov., Gimesia fumaroli sp. nov. and Gimesia panareensis sp. nov., isolated from aquatic habitats of the Northern Hemisphere

    Published in:
    Antonie van Leeuwenhoek, 2020, v. 113, n. 12, p. 1999, doi. 10.1007/s10482-020-01489-0
    By:
    • Wiegand, Sandra;
    • Jogler, Mareike;
    • Boedeker, Christian;
    • Heuer, Anja;
    • Rast, Patrick;
    • Peeters, Stijn H.;
    • Jetten, Mike S. M.;
    • Kaster, Anne-Kristin;
    • Rohde, Manfred;
    • Kallscheuer, Nicolai;
    • Jogler, Christian
    Publication type:
    Article
    30
    31
    32
    33

    A family-based study of gene variants and maternal folate and choline in neuroblastoma: a report from the Children's Oncology Group.

    Published in:
    2016
    By:
    • Mazul, Angela;
    • Siega-Riz, Anna;
    • Weinberg, Clarice;
    • Engel, Stephanie;
    • Zou, Fei;
    • Carrier, Kathryn;
    • Basta, Patricia;
    • Vaksman, Zalman;
    • Maris, John;
    • Diskin, Sharon;
    • Maxen, Charlene;
    • Naranjo, Arlene;
    • Olshan, Andrew;
    • Mazul, Angela L;
    • Siega-Riz, Anna Maria;
    • Weinberg, Clarice R;
    • Engel, Stephanie M;
    • Carrier, Kathryn S;
    • Basta, Patricia V;
    • Maris, John M
    Publication type:
    journal article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.

    Published in:
    British Journal of Haematology, 2008, v. 143, n. 3, p. 395, doi. 10.1111/j.1365-2141.2008.07365.x
    By:
    • Rezvani, Andrew R.;
    • Norasetthada, Lalitha;
    • Gooley, Ted;
    • Sorror, Mohamed;
    • Bouvier, Michelle E.;
    • Sahebi, Firoozeh;
    • Agura, Edward;
    • Chauncey, Thomas;
    • Maziarz, Richard T.;
    • Maris, Michael;
    • Shizuru, Judith;
    • Bruno, Benedetto;
    • Bredeson, Christopher;
    • Lange, Thoralf;
    • Yeager, Andrew;
    • Sandmaier, Brenda M.;
    • Storb, Rainer F.;
    • Maloney, David G.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931.

    Published in:
    Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01641
    By:
    • Ozkaynak, M. Fevzi;
    • Gilman, Andrew L.;
    • London, Wendy B.;
    • Naranjo, Arlene;
    • Diccianni, Mitchell B.;
    • Tenney, Sheena C.;
    • Smith, Malcolm;
    • Messer, Karen S.;
    • Seeger, Robert;
    • Reynolds, C. Patrick;
    • Smith, L. Mary;
    • Shulkin, Barry L.;
    • Parisi, Marguerite;
    • Maris, John M.;
    • Park, Julie R.;
    • Sondel, Paul M.;
    • Yu, Alice L.
    Publication type:
    Article
    50

    A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931.

    Published in:
    Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01355
    By:
    • Ozkaynak, M. Fevzi;
    • Gilman, Andrew L.;
    • London, Wendy B.;
    • Naranjo, Arlene;
    • Diccianni, Mitchell B.;
    • Tenney, Sheena C.;
    • Smith, Malcolm;
    • Messer, Karen S.;
    • Seeger, Robert;
    • Reynolds, C. Patrick;
    • Smith, L. Mary;
    • Shulkin, Barry L.;
    • Parisi, Marguerite;
    • Maris, John M.;
    • Park, Julie R.;
    • Sondel, Paul M.;
    • Yu, Alice L.
    Publication type:
    Article